Paris - Delayed Quote EUR
MedinCell S.A. (MEDCL.PA)
14.93
-0.54
(-3.49%)
At close: 5:35:27 PM GMT+2
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Operating Cash Flow
-11,922
-11,922
-21,005
-21,362
-12,134
Investing Cash Flow
-613
-613
1,298
-316
-1,062
Financing Cash Flow
25,528
25,528
1,556
-800
47,917
End Cash Position
19,460
19,460
6,467
24,617
47,095
Capital Expenditure
-1,191
-1,191
-1,027
-1,974
-819
Issuance of Capital Stock
23,321
23,321
810
48
42,285
Issuance of Debt
13,843
13,843
29,976
3,308
18,706
Repayment of Debt
-8,767
-8,767
-24,148
-2,307
-9,265
Repurchase of Capital Stock
-25
-25
--
-192
--
Free Cash Flow
-13,113
-13,113
-22,032
-23,336
-12,953
3/31/2021 - 10/8/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
TGNA.F Transgene SA
0.5780
+1.40%
IPH.PA Innate Pharma S.A.
1.9200
-1.64%
ADOC.PA Adocia SA
4.5250
-13.65%
DBV.PA DBV Technologies S.A.
1.9900
-12.33%
VLA.PA Valneva SE
2.8020
-3.04%
1177.HK SINO BIOPHARM
3.900
-2.50%
CLRB Cellectar Biosciences, Inc.
0.2505
+4.07%
LPCN Lipocine Inc.
3.5401
+12.03%
CRBP Corbus Pharmaceuticals Holdings, Inc.
6.95
-1.35%
GNPX Genprex, Inc.
0.2365
+6.05%